Concepedia

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C

Martin C. Müller, Norbert Gattermann, Tanja Lahaye, Michael W. Deininger, A Berndt, Stefan Früehauf, Andreas Neubauer, Thomas Fischer, Dieter K. Hossfeld, Folker Schneller,

Leukemia · 2003 · 126 citations · 37 references

DOI

Concepts

References

37

A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

Janet D. Rowley · Nature · 1973 · 4.3K citations

, , +17

Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Stephen G. O’Brien, François Guilhot, Richard A. Larson et al. · New England Journal of Medicine · 2003 · 3.6K citations · Full text

, , +10

Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia

Hagop Kantarjian, Charles L. Sawyers, Andreas Hochhaus et al. · New England Journal of Medicine · 2002 · 2K citations · Full text

, , +14

Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

J Groffen, John Stephenson, Nora Heisterkamp et al. · Cell · 1984 · 1.6K citations

, , +9

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

Susan M. Graham, Heather G. Jørgensen, Elaine Allan et al. · Blood · 2002 · 1.2K citations · Full text

, , +13